According to the present study, Notch1/2/3/4 could be potential therapeutic targets for GC, and transcription levels of Notch1/2/3/4 could be potential prognostic markers overall promoting GC survival and prognostic accuracy. This evidence concerns the gene NOTCH1 and gastric cancer.